RDNT Stock Analysis: Buy, Sell, or Hold?
RDNT - RadNet, Inc. Common Stock
$55.76
2.02 (3.76%)
▲
5d:
-1.68%
30d:
+2.86%
90d:
-9.32%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When RDNT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RDNT appears deeply undervalued. Market expects -7.0% annual earnings decline despite 75% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: RDNT appears deeply undervalued. Market expects -7.0% annual earnings decline despite 75% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$45.92
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$28.51
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RDNT is currently trading at $55.76, which is considered slightly low relative to its 30-day fair value range of $52.98 to $56.29. From a valuation perspective, the stock is trading at a discount (Forward PE: 59.1) compared to its historical average (73.4). Remarkably, the market is currently pricing in an annual earnings decline of 7.0% over the next few years. This pessimistic expectation contrasts with the company's recent 75.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, RDNT is in a strong downtrend. The price is approaching resistance at $56.31. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: RDNT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $89.75 (+61.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RDNT is in a strong downtrend. The price is approaching resistance at $56.31. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.8% recently.
Market Sentiment: RDNT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $89.75 (+61.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$52.98 -
$56.29
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
95.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.8%)
- BULLISH: Trading 61.0% below Wall St target ($89.75)
Trading Range Analysis
30-Day Trading Range
$52.98 -
$56.29
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$51.60
Resistance Level
$56.31
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
59.11
Wall Street Target
$89.75
(+61.0%)
Revenue Growth (YoY)
22.1%
Earnings Growth (YoY)
75.0%
Profit Margin
-0.7%
Valuation Discount vs History
-7.0% cheaper
PE vs Historical
59.1 vs 73.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.0%
(market-implied from PE analysis)
1-Year Target
$51.86
(-7%)
2-Year Target
$48.23
(-14%)
3-Year Target
$44.85
(-20%)
3-Yr Target (if PE normalizes)
(PE: 59→73)
$55.69
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 59.1, Growth: 82.9%)
$188.19
(+238%)
Base:
(SPY PE: 21.8, Growth: 82.9%)
$69.34
(+24%)
Bear:
(PE: 18.5, Growth: 82.9%)
$58.94
(+6%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 59.1 to 73.4
Stabilization Target:
$69.24
(+24.2%)
PE Expansion Potential:
+24.2%
Share & Embed Analysis
Last updated: June 23, 2026 8:25 AM ET
Data refreshes hourly during market hours. Next update: 9:25 AM
Data refreshes hourly during market hours. Next update: 9:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RDNT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Alma Gregory Sorensen
SELL
15000 shares
2026-03-18
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$142 | 56 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 51 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 62 BUY |
Advanced RDNT Option Strategies
Professional options setups generated by AI based on today's RDNT price and gamma walls.
